[go: up one dir, main page]

TW202142276A - Wound healing kit for producing artificial scabs - Google Patents

Wound healing kit for producing artificial scabs Download PDF

Info

Publication number
TW202142276A
TW202142276A TW109115838A TW109115838A TW202142276A TW 202142276 A TW202142276 A TW 202142276A TW 109115838 A TW109115838 A TW 109115838A TW 109115838 A TW109115838 A TW 109115838A TW 202142276 A TW202142276 A TW 202142276A
Authority
TW
Taiwan
Prior art keywords
wound
collagen
gel
present
collagen gel
Prior art date
Application number
TW109115838A
Other languages
Chinese (zh)
Other versions
TWI754279B (en
Inventor
王祥宇
曾俞靜
綦孟柔
Original Assignee
國立屏東科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立屏東科技大學 filed Critical 國立屏東科技大學
Priority to TW109115838A priority Critical patent/TWI754279B/en
Publication of TW202142276A publication Critical patent/TW202142276A/en
Application granted granted Critical
Publication of TWI754279B publication Critical patent/TWI754279B/en

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a wound healing kit for producing artificial scabs, including a bacterial cellulose membrane and collagen gel. The invention also relates to a patch for producing artificial scabs and use of bacterial cellulose membranes and collagen gel in the manufacture of artificial scabs for wound healing.

Description

用以產生人工痂皮的傷口修復套組Wound repair kit for producing artificial scab

本發明係關於一種用以產生人工痂皮的傷口修復套組,特別是一種包含生物纖維膜與膠原蛋白凝膠的傷口修復套組。The present invention relates to a wound repair kit for producing artificial scabs, in particular a wound repair kit containing bio-fiber membrane and collagen gel.

傷口的型態種類可大致區分為:急性出血傷口、慢性發炎傷口、深層難癒合傷口,其中在許多出血量不足以產生結痂的傷口,缺乏痂皮提供外部阻隔覆蓋,導致傷口直接暴露於外在環境,受細菌病毒沾黏感染而發炎,結果傷口復原緩慢且容易產生疤痕組織,並可能進一步導致嚴重的感染與截肢。The types of wounds can be roughly divided into: acute bleeding wounds, chronic inflammatory wounds, and deep wounds that are difficult to heal. Among them, many wounds with insufficient bleeding to produce scabs, lack of scabs to provide external barrier coverage, resulting in direct exposure of the wound to the outside. In the environment, infections caused by bacteria and viruses become inflamed. As a result, wounds recover slowly and scar tissue is easily produced, which may further lead to serious infections and amputations.

慢性發炎傷口中的壓傷,常見於長時間受到壓迫的區域,例如久病臥床的患者臀部的褥瘡或四足動物長期趴臥時的腹部壓瘡。此類壓傷對外的傷口,無法形成痂皮保護性外層,導致傷口復原緩慢,甚至反覆發炎導致受損範圍擴大。因此,若能以適當的生物材料產生人工痂皮,覆蓋傷口,模擬接近自然傷口復原的細胞微環境,以達到降低換藥頻率、隔絕外部感染源,以及減少疤痕組織的效果,將可對人類及動物的傷口照護提供有效的幫助。Compression injuries in chronic inflamed wounds are common in areas that have been under pressure for a long time, such as bedsores on the buttocks of patients who have been bedridden for a long time or abdominal pressure sores when quadrupeds lie on their stomachs for a long time. The external wound of this type of pressure injury cannot form a protective outer layer of crust, resulting in slow recovery of the wound, and even repeated inflammation leading to the expansion of the damaged area. Therefore, if an artificial scab can be produced with appropriate biological materials to cover the wound and simulate the cell microenvironment close to natural wound recovery, so as to reduce the frequency of dressing changes, isolate external sources of infection, and reduce scar tissue, it will be beneficial to humans. And provide effective help for animal wound care.

於一方面,本發明涉及一種用以產生人工痂皮的傷口修復套組。In one aspect, the present invention relates to a wound repair kit for producing artificial crust.

於另一方面,本發明涉及一種用以產生人工痂皮的貼片。In another aspect, the present invention relates to a patch for producing artificial crust.

於又一方面,本發明涉及一種生物纖維膜與膠原蛋白凝膠在製備治療傷口的人工痂皮之用途。In another aspect, the present invention relates to the use of a bio-fiber membrane and collagen gel in the preparation of artificial crust for treating wounds.

本發明係以下面的實施例予以示範闡明,但本發明不受下述實施例所限制。The present invention is illustrated by the following examples, but the present invention is not limited by the following examples.

本發明提供一種用以產生人工痂皮的傷口修復套組,包含一生物纖維膜,以及一膠原蛋白凝膠,該膠原蛋白凝膠包含約50~250 µg/mL膠原蛋白、約150~250 mg/mL凝膠,以及約0~50 µg/mL抗菌劑。The present invention provides a wound repair kit for producing artificial scabs, which includes a biofiber membrane and a collagen gel. The collagen gel contains about 50-250 µg/mL collagen and about 150-250 mg. /mL gel, and about 0-50 µg/mL antibacterial agent.

本發明並提供一種用以產生人工痂皮的貼片,包含一生物纖維膜,該生物纖維膜具有第一表面及第二表面,該第一表面上具有一膠原蛋白凝膠層,該膠原蛋白凝膠層係用於與一使用者接觸,使該生物纖維膜貼附於該使用者。The present invention also provides a patch for producing artificial scabs, comprising a biofiber membrane having a first surface and a second surface, the first surface has a collagen gel layer, and the collagen The gel layer is used to contact a user, so that the bio-fiber membrane is attached to the user.

本發明並提供一種生物纖維膜與膠原蛋白凝膠在製備治療傷口的人工痂皮之用途。The invention also provides a use of bio-fiber membrane and collagen gel in preparing artificial crust for treating wounds.

於某些具體實施例中,該膠原蛋白凝膠包含約50~250 µg/mL膠原蛋白、約150~250 mg/mL凝膠,以及約0~50 µg/mL抗菌劑。In some embodiments, the collagen gel contains about 50-250 µg/mL collagen, about 150-250 mg/mL gel, and about 0-50 µg/mL antibacterial agent.

於某些具體實施例中,該膠原蛋白的濃度為約50~250 µg/mL,較佳包括但不限於約50、約60、約70、約80、約90、約100、約110、約120、約130、約140、約150、約160、約170、約180、約190、約200、約210、約220、約230、約240、約250 µg/mL,或為50~250 µg/mL任一濃度,不限為整數之濃度,例如,但不限於168.56 µg/mL、203.7 µg/mL等;於某些具體實施例中,膠原蛋白的濃度為約100 µg/mL。In some embodiments, the concentration of the collagen is about 50~250 µg/mL, preferably including but not limited to about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250 µg/mL, or 50~250 µg Any concentration of /mL is not limited to an integer concentration, such as, but not limited to, 168.56 µg/mL, 203.7 µg/mL, etc.; in some specific embodiments, the concentration of collagen is about 100 µg/mL.

於某些具體實施例中,該凝膠的濃度為約150~250 mg/mL,較佳包括但不限於約150、約160、約170、約180、約190、約200、約210、約220、約230、約240、約250 mg/mL,或為150~250 mg/mL任一濃度,不限為整數之濃度,例如,但不限於196.47 mg/mL、226.87 mg/mL等;於某些具體實施例中,該凝膠的濃度為約180~200 mg/mL。In some embodiments, the concentration of the gel is about 150~250 mg/mL, preferably including but not limited to about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250 mg/mL, or any concentration of 150-250 mg/mL, not limited to an integer concentration, for example, but not limited to 196.47 mg/mL, 226.87 mg/mL, etc.; In some specific embodiments, the concentration of the gel is about 180-200 mg/mL.

於某些具體實施例中,該抗菌劑的濃度為約0~50 µg/mL,較佳包括但不限於約1、約5、約10、約15、約20、約25、約30、約35、約40、約45、約 50 µg/mL,或為0~50 µg/mL任一濃度,不限為整數之濃度,例如,但不限於0.01、3.47、28.94 µg/mL等;於某些具體實施例中,該抗菌劑的濃度為約30 µg/mL。In some embodiments, the concentration of the antibacterial agent is about 0-50 µg/mL, preferably including but not limited to about 1, about 5, about 10, about 15, about 20, about 25, about 30, about 35, about 40, about 45, about 50 µg/mL, or any concentration of 0-50 µg/mL, not limited to an integer concentration, for example, but not limited to 0.01, 3.47, 28.94 µg/mL, etc.; In some embodiments, the concentration of the antibacterial agent is about 30 µg/mL.

本發明之傷口修復套組可用於各類型的傷口,例如:大面積燒燙傷、壓瘡(亦即壓傷,又稱褥瘡)、糖尿病患者的傷口,以及各種不同深度的傷口皆可使用。此外,本發明之傷口修復套組可用於人類、家畜、寵物,甚至不同型態大小的野生動物。當用於動物時,因本發明之傷口修復套組可促進傷口修復且換藥頻率低,可降低動物因換藥的不適而需要固定或麻醉等管理上的成本及不便。The wound repair kit of the present invention can be used for various types of wounds, such as: large-area burns and scalds, pressure sores (also called pressure sores), diabetic wounds, and wounds of various depths. In addition, the wound repair kit of the present invention can be used for humans, domestic animals, pets, and even wild animals of different types and sizes. When used in animals, because the wound repair kit of the present invention can promote wound repair and the frequency of dressing is low, it can reduce the cost and inconvenience of management such as immobilization or anesthesia for animals due to the discomfort of dressing change.

本發明之傷口修復套組操作方便,使用前建議先進行傷口前處理,視傷口需求刮除傷口周圍毛髮,使用生理食鹽水清洗傷口,並以碘液等消毒劑擦拭傷口周圍皮膚。完成傷口前處理後,依照傷口大小剪裁所需的生物纖維膜面積,較佳為大於傷口面積邊緣1~2 公分,以確保生物纖維膜可覆蓋整個傷口;若傷口面積大於單張生物纖維膜面積,則可將複數張生物纖維膜以邊界重疊1~2公分的方式使用;將膠原蛋白凝膠以類似膠水的方式塗抹至剪裁好的生物纖維膜後,再完整的貼附於要處理的傷口上,即完成本發明之傷口修復套組的操作。使用本發明所形成的人工痂皮通常不需更換,亦即不需換藥,待下層皮膚癒合後,該人工痂皮將以類似自然痂皮碎裂的方式脫落。若因傷口清創不完全而導致使用後感染,則可於重新清創後,再以上述步驟使用本發明之傷口修復套組,重新形成人工痂皮。The wound repair kit of the present invention is easy to operate. It is recommended to pre-treat the wound before use, shave the hair around the wound according to the needs of the wound, clean the wound with saline solution, and wipe the skin around the wound with disinfectant such as iodine solution. After finishing the pre-treatment of the wound, cut the required bio-fiber membrane area according to the size of the wound, preferably 1~2 cm larger than the edge of the wound area to ensure that the bio-fiber membrane can cover the entire wound; if the wound area is larger than the area of a single bio-fiber membrane , You can use a plurality of bio-fiber membranes with the boundary overlapping by 1~2 cm; apply the collagen gel to the cut bio-fiber membrane in a glue-like manner, and then completely attach it to the wound to be treated Above, the operation of the wound repair kit of the present invention is completed. The artificial crust formed by using the present invention usually does not need to be replaced, that is, there is no need to change the dressing. After the lower layer of skin is healed, the artificial crust will fall off in a manner similar to the fragmentation of natural crust. If the wound is infected after use due to incomplete debridement, the wound repair kit of the present invention can be used in the above steps after re-debridement to re-form artificial crust.

除非另有定義,本文使用的所有技術及科學術語具有與本發明所屬領域中的技術人員所通常理解相同的含義。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the present invention belongs.

如本文所用,除非上下文另有明確規定,單數形式「一」、「一個」,以及「該」包括複數參照物。因此,例如,提及「一個部件」包括本領域技術人員已知的多個這樣的部件及其等同物。As used herein, unless the context clearly dictates otherwise, the singular forms "a", "an", and "the" include plural references. Thus, for example, reference to "a component" includes a plurality of such components and their equivalents known to those skilled in the art.

如本文所用,「大約」、「約」或「近似」通常意指在給定值或範圍內的20%以內,較佳在10%以內,更佳在5%以內。本文所給之數量為近似值,其代表若無明確說明時,可以推斷是指術語「大約」、「約」或「近似」。As used herein, "about", "about" or "approximately" generally means within 20% of a given value or range, preferably within 10%, more preferably within 5%. The quantities given in this article are approximate, and unless explicitly stated, they can be inferred to refer to the terms "approximately", "approximately" or "approximately".

如本文所用,術語「生物纖維」,又稱「細菌纖維素(bacterial cellulose)」係指由細菌產生之具有(C6 H10 O5 )n 化學式的有機化合物,其為D-葡萄糖的線性聚合物,透過β-(1,4)糖苷鍵連接,並具有以下之分子結構:

Figure 02_image001
。 生物纖維的直徑約為20~100 nm。可產生生物纖維的細菌菌屬包含,但不限於,醋桿菌(Acetobacter )、固氮菌(Azotobacter )、醋酸菌(Komagateibacter )、根瘤菌(Rhizobium )、假單胞菌(Pseudomonas )、沙門氏菌(Salmonella )、產鹼菌(Alcaligenes ),以及八疊球菌(Sarcina );實例包含,但不限於,木醋桿菌(Acetobacter xylinum )、漢氏醋桿菌(Acetobacter hansenii )、巴氏醋桿菌(Acetobacter pasteurianus )、漢氏糖桿菌(Gluconacetobacter hansenii )、木糖葡糖桿菌(Gluconacetobacter xylinus )、木質醋酸菌(Komagataeibacter xylinus )。As used herein, the term "biological fiber", also known as "bacterial cellulose" refers to an organic compound with the chemical formula (C 6 H 10 O 5 ) n produced by bacteria, which is a linear polymerization of D-glucose It is connected by β-(1,4) glycosidic bond and has the following molecular structure:
Figure 02_image001
. The diameter of biological fiber is about 20-100 nm. Fibers can be produced biologically bacterial species include, but are not limited to, Acetobacter (by Acetobacter), nitrogen-fixing bacteria (Azotobacter), acetic acid bacteria (Komagateibacter), Rhizobium (with Rhizobium), Pseudomonas (of Pseudomonas), Salmonella (Salmonella) , Alcaligenes , and Sarcina ; examples include, but are not limited to, Acetobacter xylinum , Acetobacter hansenii , Acetobacter pasteurianus , and Chinese Gluconacetobacter hansenii , Gluconacetobacter xylinus , Komagataeibacter xylinus .

如本文所用,術語「生物纖維膜」係指以生物纖維(又稱細菌纖維素)為原料所製成之具有不織布結構的薄膜。生物纖維膜的孔隙極小,可使空氣與水分子通過,保持傷口所需的溼度,但同時隔絕所有微生物(包括細菌與病毒)的穿透。本發明中使用的生物纖維膜pH值為約7.0 +/- 1.0,含水率為約4%~20% (w/w) ,厚度為約5~25 µm,,基重為約10~30 g/m2 ,經高溫高壓或γ-射線滅菌,且無熱源(pyrogen)。可用於本發明之生物纖維膜可經由商購獲得,例如,但不限於, DermaFill® (Cellulose Solutions L.L.C.公司,阿拉巴馬州,美國)。As used herein, the term "biological fiber membrane" refers to a film with a non-woven structure made of biological fiber (also known as bacterial cellulose) as a raw material. The pores of the bio-fiber membrane are extremely small, allowing air and water molecules to pass through, maintaining the humidity required by the wound, but at the same time blocking the penetration of all microorganisms (including bacteria and viruses). The pH value of the biofiber membrane used in the present invention is about 7.0 +/- 1.0, the water content is about 4%-20% (w/w), the thickness is about 5-25 µm, and the basis weight is about 10-30 g /m 2 , sterilized by high temperature, high pressure or γ-ray, and no pyrogen. The biofiber membrane that can be used in the present invention is commercially available, such as, but not limited to, DermaFill® (Cellulose Solutions LLC, Alabama, USA).

如本文所用,術語「膠原蛋白凝膠」係指含有膠原蛋白的凝膠製劑。本發明之膠原蛋白凝膠可進一步包含一抗菌劑。本發明之膠原蛋白凝膠可作為該生物纖維膜的黏著劑,使該生物纖維膜黏附於所要處理的傷口表面。此外,該膠原蛋白凝膠中的膠原蛋白可加速傷口復原,若含有抗菌劑則可達到抗菌之效果。As used herein, the term "collagen gel" refers to a gel formulation containing collagen. The collagen gel of the present invention may further include an antibacterial agent. The collagen gel of the present invention can be used as an adhesive of the biological fiber membrane to make the biological fiber membrane adhere to the surface of the wound to be treated. In addition, the collagen in the collagen gel can accelerate wound healing, and if it contains antibacterial agents, it can achieve antibacterial effects.

如本文所用,術語「膠原蛋白」係指動物體內各種結締組織中胞外基質的主要結構蛋白,其分子結構呈三股螺旋,由三條多胜肽(polypeptide)相互纏繞構成。膠原蛋白的來源包含但不限於陸生動物(如,雞、鴨、鵝、豬、牛、羊、驢、馬等)與水生動物(如,魚類、棘皮動物、頭足類動物、貝類等)。於一具體實施例中,本發明之膠原蛋白凝膠使用魚類膠原蛋白,其分子量介於但不限於約100 kDa至約220 kDa。As used herein, the term "collagen" refers to the main structural protein of the extracellular matrix in various connective tissues in animals. Its molecular structure is a triple helix and is composed of three polypeptides entangled with each other. Sources of collagen include, but are not limited to, terrestrial animals (eg, chickens, ducks, geese, pigs, cattle, sheep, donkeys, horses, etc.) and aquatic animals (eg, fish, echinoderms, cephalopods, shellfish, etc.). In a specific embodiment, the collagen gel of the present invention uses fish collagen, which has a molecular weight ranging from, but not limited to, about 100 kDa to about 220 kDa.

如本文所用,術語「凝膠」係指非流動性的膠態網絡共聚物或連續的整個體積由流體膨脹的網絡共聚物。凝膠具有半固體、在穩態時不具流動性等特性。可用於本發明之凝膠包含各種類型的共聚物,例如,但不限於,高分子親水性凝膠(hydrogel) [例如,嵌段共聚物泊洛沙姆(Poloxamer) 407、泊洛沙姆181、普朗尼克(Pluronics) L61;聚丙烯酸(Poly(acrylic acid))、聚甲基丙烯酸(polymethylacrylic acid)、聚丙烯醯胺(Polyacrylamide)]、多胜肽凝膠[例如,聚L -離胺酸(poly-L-lysine)、聚L-麩胺酸(poly(L-glutamic acid))、膠原蛋白]、多醣類凝膠(例如,纖維素、澱粉、透明質酸、海藻酸、幾丁聚醣)。於某些具體實施例中,以嵌段共聚物泊洛沙姆407為凝膠材料。泊洛沙姆為以聚氧丙烯鏈接兩段親水聚氧乙烯所構成得非離子式三嵌段共聚物,其具有兩性分子結構,增加疏水油性物質的水溶性或增加不同疏水物質的溶混性。於該些具體實施例中,泊洛沙姆407與膠原蛋白結合後,形成膠原蛋白凝膠。As used herein, the term "gel" refers to a non-flowing colloidal network copolymer or a continuous network copolymer whose entire volume is swelled by a fluid. The gel is semi-solid and does not have the characteristics of fluidity in a steady state. The gel that can be used in the present invention includes various types of copolymers, such as, but not limited to, polymer hydrophilic gels (hydrogel) [e.g., block copolymer Poloxamer 407, Poloxamer 181 , Pluronics L61; poly(acrylic acid), polymethylacrylic acid, polyacrylamide], multi-peptide gel [e.g., poly-L-lysine Acid (poly-L-lysine), poly-L-glutamic acid (poly(L-glutamic acid), collagen], polysaccharide gels (e.g., cellulose, starch, hyaluronic acid, alginic acid, Buttosan). In some embodiments, the block copolymer poloxamer 407 is used as the gel material. Poloxamer is a non-ionic triblock copolymer composed of polyoxypropylene linking two hydrophilic polyoxyethylene. It has an amphoteric molecular structure, which increases the water solubility of hydrophobic oily substances or the miscibility of different hydrophobic substances . In these embodiments, poloxamer 407 is combined with collagen to form a collagen gel.

如本文所用,術語「抗菌劑(antimicrobial)」係指殺死微生物或阻止其生長的試劑。可用於本發明之膠原蛋白凝膠的抗菌劑之種類包含,但不限於,金屬離子抗菌劑、金屬奈米顆粒抗菌劑、天然精油抗菌劑、多胺類抗菌劑。於某些具體實施例中,本發明之膠原蛋白凝膠中添加奈米銀作為抗菌劑。As used herein, the term "antimicrobial" refers to an agent that kills microorganisms or prevents their growth. The types of antibacterial agents that can be used in the collagen gel of the present invention include, but are not limited to, metal ion antibacterial agents, metal nanoparticle antibacterial agents, natural essential oil antibacterial agents, and polyamine antibacterial agents. In some embodiments, nanosilver is added to the collagen gel of the present invention as an antibacterial agent.

如本文所用,術語「人工痂皮」係指由本發明之套組所包含的生物纖維膜以及膠原蛋白凝膠,加上受試者本身傷口組織滲液中的蛋白,共同形成的痂皮結構。本發明之生物纖維膜的生物相容性極高,貼附於傷口表面作為隔絕微生物的外層,而該生物纖維膜與傷口之間的膠原蛋白凝膠,除了使該生物纖維膜黏附於傷口表面之外,亦會與傷口組織滲出液中的蛋白作用,在水分蒸散後,該生物纖維膜、該膠原蛋白凝膠,以及傷口組織滲出液中的蛋白三者積聚變硬,形成類似痂皮的層疊,此即為人工痂皮結構。本發明之人工痂皮結構覆蓋於傷口上,提供可促進傷口修復的微環境,加速傷口癒合,並減少換藥頻率。As used herein, the term "artificial scab" refers to a scab structure formed by the biofiber membrane and collagen gel contained in the kit of the present invention, plus the protein in the subject's own wound tissue exudate. The bio-fiber membrane of the present invention has extremely high biocompatibility and is attached to the wound surface as an outer layer to isolate microorganisms. The collagen gel between the bio-fiber membrane and the wound, in addition to making the bio-fiber membrane adhere to the wound surface In addition, it will also interact with the protein in the wound tissue exudate. After the water evaporates, the biofibrous membrane, the collagen gel, and the protein in the wound tissue exudate will accumulate and become hard, forming a scab-like Layered, this is the artificial scab structure. The artificial crust structure of the present invention covers the wound, provides a microenvironment that can promote wound repair, accelerates wound healing, and reduces the frequency of dressing changes.

於以下的說明性實施例中更詳細地描述本發明。儘管實施例可以僅代表本發明的選定具體實施例,但是應當理解的是,以下實施例為說明性的而非限制性的。The present invention is described in more detail in the following illustrative examples. Although the embodiments may only represent selected specific embodiments of the present invention, it should be understood that the following embodiments are illustrative and not restrictive.

實施例Example

實施例一Example one 人類上臂內側燒燙傷修復試驗Repair test of burn and scald on the inner side of human upper arm

試驗材料:本發明之傷口修復套組,包含生物纖維膜(pH值為約7.0 +/- 1.0,含水率為約4%~20% (w/w),厚度為約5~25 µm,基重為約10~30 g/m2 ,經高溫高壓或γ-射線滅菌,且無熱源),以及膠原蛋白凝膠(含有100 µg/mL鱸鰻魚皮膠原蛋白、180~200 mg/mL泊洛沙姆407、30 µg/mL奈米銀,以無菌水配製)。Test material: The wound repair kit of the present invention contains bio-fiber membrane (pH value is about 7.0 +/- 1.0, water content is about 4%-20% (w/w), thickness is about 5-25 µm, base It weighs about 10~30 g/m 2 , sterilized by high temperature, high pressure or γ-ray, and no heat source), and collagen gel (containing 100 µg/mL perch eel skin collagen, 180~200 mg/mL Polot Sham 407, 30 µg/mL nanosilver, prepared with sterile water).

試驗對象:人類受試者(蒙古人種,男性,39歲)左手上臂內側以醫學美容用的雷射造成二處燒燙傷。每處傷口的雷射波長為1064 nm,雷射劑量為3.2 J/cm2 ,雷射面積為19.8*19.8 mm2 ,覆蓋率為88%。Test object: A human subject (Mongolian race, male, 39 years old) suffered two burns and scalds on the inner side of his left arm with a medical cosmetic laser. The laser wavelength of each wound is 1064 nm, the laser dose is 3.2 J/cm 2 , the laser area is 19.8*19.8 mm 2 , and the coverage rate is 88%.

試驗方法:上述雷射處理後隨機選一處傷口為對照組,僅進行消毒處理,消毒處理方法為:以生理食鹽水清洗傷口並以碘液等消毒劑擦拭傷口周圍皮膚;另一處傷口為試驗組,進行與對照組相同的消毒處理後,使用本發明之傷口修復套組持續25天,方法如下:剪裁所需的生物纖維膜,使其面積大於傷口面積邊緣 1~2 公分,以確保可覆蓋整個傷口;將膠原蛋白凝膠以類似塗膠水的方式塗抹至該生物纖維膜的任一面(將與傷口接觸的那面)後,再將塗抹有膠原蛋白凝膠的該生物纖維膜的表面貼附於該試驗組傷口上共25天,期間未更換生物纖維膜。進行後續觀察並拍照記錄。Test method: After the above-mentioned laser treatment, one wound was randomly selected as the control group, and only disinfected. The disinfection treatment method is: wash the wound with saline and wipe the skin around the wound with a disinfectant such as iodine solution; the other wound is In the test group, after the same disinfection treatment as the control group, the wound repair kit of the present invention was used for 25 days. The method is as follows: cut the required bio-fiber membrane to make the area 1~2 cm larger than the edge of the wound area to ensure It can cover the entire wound; after applying the collagen gel to any side of the bio-fiber membrane (the side that will be in contact with the wound) in a manner similar to applying glue, then apply the collagen gel to the bio-fiber membrane The surface was attached to the wound of the test group for a total of 25 days, during which the biofiber membrane was not replaced. Make follow-up observations and take photos for recording.

結果:如圖1A至圖1F所示。試驗組傷口於燒燙傷發生後第2天即形成人工痂皮結構,而對照組傷口則由自體組織緩慢形成自然痂皮結構(如圖1A所示)。於第8天可觀察到試驗組傷口上的人工痂皮逐漸均勻地變厚,而對照組傷口則由自體組織形成自然且不均勻的痂皮結構,傷口周圍的痂皮較厚,而傷口中央的痂皮較薄(如圖1B所示)。於第12天可觀察到試驗組傷口上的人工痂皮部分明顯硬化但結構仍然完整,而對照組傷口由自體組織所形成的自然痂皮結構仍不均勻(如圖1C所示)。於第25天時試驗組傷口已癒合至該人工痂皮完全脫落,而對照組傷口由自體組織所形成的自然痂皮結構碎裂且部分脫落,造成傷口再度暴露於外甚至感染出血(如圖1D所示)。於第53天時試驗組傷口與對照組傷口皆已復原,但對照組傷口處產生明顯的疤痕組織,而試驗組傷口處則無此疤痕組織(如圖1E所示)。追蹤3年後,可觀察到試驗組傷口處僅有部分色素沉積現象但傷口處皮膚平整,而對照組傷口處則有明顯疤痕組織生成,具有突出類似肉芽的結構(如圖1F所示)。Result: as shown in Figure 1A to Figure 1F. The wound of the test group formed an artificial crust structure on the second day after the burn and scald, while the wound of the control group slowly formed a natural crust structure from autologous tissue (as shown in Figure 1A). On the 8th day, it can be observed that the artificial crust on the wound of the test group became thicker gradually and uniformly, while the wound of the control group formed a natural and uneven crust structure from autologous tissue. The crust around the wound was thicker and the wound The central crust is thinner (as shown in Figure 1B). On the 12th day, it can be observed that the artificial crust part of the wound in the test group is obviously hardened but the structure is still intact, while the natural crust structure formed by the autologous tissue in the control group is still uneven (as shown in Figure 1C). On day 25, the wound in the test group had healed until the artificial crust completely fell off, while the natural crust structure formed by autologous tissue in the control group was fragmented and partially peeled off, causing the wound to be exposed again and even infected and bleeding (such as Shown in Figure 1D). On the 53rd day, both the wounds of the test group and the control group had recovered, but obvious scar tissue was produced at the wound of the control group, while there was no such scar tissue at the wound of the test group (as shown in Fig. 1E). After tracking for 3 years, it can be observed that the test group has only partial pigmentation at the wound but the skin is flat, while the control group has obvious scar tissue formation in the wound, with a prominent granulation-like structure (as shown in Figure 1F).

由此可知,本發明之傷口修復套組操作方便,不需頻繁換藥,並可加速人類皮膚形成痂皮結構,縮短傷口癒合時間,且癒合後的傷口疤痕不明顯。It can be seen that the wound repair kit of the present invention is easy to operate, does not require frequent dressing changes, can accelerate the formation of a scab structure on human skin, shorten the wound healing time, and the wound scars after healing are not obvious.

實施例二Example two 臺灣獼猴腹部壓瘡修復試驗Repair test of abdominal pressure sore in Taiwan macaques

試驗材料:同實施例一。Test material: Same as Example 1.

試驗對象:本實施例之動物案例為保育類野生動物收容中心(屏東,台灣)收容之靈長類台灣獼猴(Macaca cyclopsis ,雄性,預估年齡約25歲),因年老長期趴臥,姿勢不良而壓迫腹部造成大面積壓瘡。臨床血液檢驗顯示該案例有明顯的發炎反應以及輕微貧血症狀。該案例於臨床症狀中有腹瀉之情形且腹部大面積傷口明顯紅腫。Test subject: The animal case in this example is the primate Taiwanese macaque ( Macaca cyclopsis , male, estimated age about 25 years old) housed in the Wildlife Conservation Center (Pingtung, Taiwan), lying on his back for a long time due to his old age. Poor posture and pressure on the abdomen cause a large area of pressure sores. Clinical blood tests showed that this case had obvious inflammatory reaction and mild symptoms of anemia. In this case, there was diarrhea among the clinical symptoms, and a large area of the abdominal wound was obviously red and swollen.

試驗方法:首先以生理食鹽水清洗該案例之壓瘡部位,並以碘液等消毒劑擦拭壓瘡周圍皮膚;接著,由於該案例腹部壓瘡面積大於單張生物纖維膜面積,故將複數張生物纖維膜以邊界重疊1~2公分方式使用,以確保可覆蓋整個壓瘡傷口;將膠原蛋白凝膠以類似塗膠水的方式塗抹至該複數張生物纖維膜內表面(將與壓瘡傷口接觸的那面)後,再將塗抹有膠原蛋白凝膠的該複數張生物纖維膜的內表面,以邊界重疊1~2公分方式貼附於該案例腹部壓瘡傷口上共23天,因壓瘡嚴重,故每3~4天以本發明之傷口修復套組更換一次。進行後續觀察,每3~4天觀察一次,並拍照記錄。Test method: First, clean the pressure ulcer in this case with saline solution, and wipe the skin around the pressure ulcer with iodine solution and other disinfectants; then, because the area of the pressure ulcer in the abdomen in this case is larger than the area of a single biofiber membrane, multiple sheets The bio-fiber membrane is used in a way that the boundary overlaps by 1~2 cm to ensure that the entire pressure ulcer wound can be covered; the collagen gel is applied to the inner surface of the plurality of bio-fiber membranes in a manner similar to glue application (will be in contact with the pressure ulcer wound) After that, the inner surface of the plurality of bio-fiber membranes coated with collagen gel was attached to the abdominal pressure ulcer wound in this case by overlapping the borders by 1 to 2 cm for 23 days. If it is serious, replace it with the wound repair kit of the present invention every 3 to 4 days. Carry out follow-up observations, observe once every 3 to 4 days, and take photos for recording.

結果:如圖2A至圖2D所示。該案例腹部壓瘡傷口於處理前明顯紅腫(如圖2A所示),於使用本發明之傷口修復套組第3天時紅腫即明顯消退(如圖2B所示),至第12天時壓瘡面積減小,傷口紅腫的情況已大幅改善(如圖2C所示),而至第23天時,壓瘡傷口已完全修復痊癒(如圖2D所示)。Result: as shown in Figure 2A to Figure 2D. In this case, the abdominal pressure ulcer wound was obviously red and swollen before treatment (as shown in Fig. 2A), and the redness and swelling disappeared significantly on the 3rd day of using the wound repair kit of the present invention (as shown in Fig. 2B), and the pressure on the 12th day The area of the sore was reduced, and the redness and swelling of the wound had been greatly improved (as shown in Fig. 2C), and by the 23rd day, the pressure sore wound had been completely healed (as shown in Fig. 2D).

由此可知,本發明之傷口修復套組操作方便,不需頻繁換藥,並可促進壓瘡傷口修復至痊癒。It can be seen that the wound repair kit of the present invention is convenient to operate, does not require frequent dressing changes, and can promote pressure ulcer wound repair to heal.

實施例三Example three 野生臺灣獼猴尾部外傷修復試驗Experiment on repairing tail trauma of wild Taiwan macaque

試驗材料:同實施例一。Test material: Same as Example 1.

試驗對象:本實施例之動物案例為保育類野生動物收容中心(屏東,台灣)收容之靈長類台灣獼猴(雄性,年齡未知),因猴群打架或其他意外因素導致尾部嚴重外傷與感染潰瘍。Test subject: The animal case in this example is a primate Taiwanese macaque (male, age unknown) housed in the Wildlife Conservation Center (Pingtung, Taiwan). The tail was severely injured and infected due to fights or other accidental factors. ulcer.

試驗方法:首先以生理食鹽水清洗該案例之尾部傷口,並以碘液等消毒劑擦拭傷口周圍皮膚;接著,將膠原蛋白凝膠以類似塗膠水的方式塗抹至生物纖維膜內表面(將與尾部傷口接觸的那面)後,再將塗抹有膠原蛋白凝膠的該生物纖維膜的內表面貼附於該案例尾部傷口上,並以紗布包覆於該生物纖維膜外層,以防止該案例因活動而使該生物纖維膜脫落。由於傷口感染嚴重,故每4天以本發明之傷口修復套組更換一次,並進行後續觀察拍照記錄。Test method: First, clean the tail wound in this case with saline solution, and wipe the skin around the wound with iodine solution and other disinfectants; then, apply collagen gel to the inner surface of the biofiber membrane in a manner similar to that of glue. After the side where the tail wound is in contact), the inner surface of the bio-fiber membrane coated with collagen gel is attached to the tail wound of the case, and the outer layer of the bio-fiber membrane is covered with gauze to prevent the case The bio-fiber membrane fell off due to activity. Due to the serious wound infection, the wound repair kit of the present invention was replaced every 4 days, and follow-up observation and photographing were performed.

結果:如圖3A至圖3D所示。該案例尾部傷口於處理前感染嚴重並有潰瘍的情形(如圖3A所示),於使用本發明之傷口修復套組第30天後組織生長回復 (如圖3B所示),至第50天時尾部傷口滲液的情況已明顯減少(如圖3C所示),於第75天時皮膚表層已完全修復(如圖3D所示)。Result: as shown in Figure 3A to Figure 3D. In this case, the tail wound was severely infected and had ulcers before treatment (as shown in Figure 3A), and the tissue growth recovered after the 30th day using the wound repair kit of the present invention (as shown in Figure 3B) to the 50th day At this time, the exudation of the tail wound has been significantly reduced (as shown in Fig. 3C), and the skin surface layer has been completely repaired on the 75th day (as shown in Fig. 3D).

由此可知,本發明之傷口修復套組操作方便,即便使用在感染嚴重的傷口上,亦不需每日換藥,可降低換藥頻率,並可促進感染嚴重的傷口修復。It can be seen that the wound repair kit of the present invention is easy to operate, even if it is used on severely infected wounds, it does not require daily dressing changes, which can reduce the frequency of dressing changes and promote the repair of severely infected wounds.

上列詳細說明係針對本發明之一可行實施例之具體說明,惟該實施例並非用以限制本發明之專利範圍,凡未脫離本發明技藝精神所為之等效實施或變更,均應包含於本案之專利範圍中。The above detailed description is a specific description of a possible embodiment of the present invention, but this embodiment is not intended to limit the scope of the patent of the present invention. Any equivalent implementation or modification that does not deviate from the technical spirit of the present invention shall be included in In the scope of the patent in this case.

綜上所述,本案所揭露之技術特徵已充分符合新穎性及進步性之法定發明專利要件,爰依法提出申請,懇請 貴局核准本件發明專利申請案,以勵發明,至感德便。In summary, the technical features disclosed in this case have fully met the statutory requirements for invention patents for novelty and advancement. I filed an application in accordance with the law, and I implore your bureau to approve this invention patent application to encourage invention.

1 所示為人類皮膚燒燙傷修復試驗結果。圖1A至圖1F所示分別為處理後第2天、第8天、第12天、第25天、第53天,以及3年後皮膚復原之情形。Con.表示對照組;Exp.表示試驗組。 Figure 1 shows the results of a burn and scald repair test on human skin. Figures 1A to 1F show the recovery of the skin on day 2, day 8, day 12, day 25, day 53, and 3 years after treatment, respectively. Con. means the control group; Exp. means the test group.

2 所示為臺灣獼猴腹部壓瘡修復試驗結果。圖2A所示為處理前壓瘡紅腫的情況,左圖為正面照,右圖為側面照;圖2B至圖2D所示分別為處理後第3天、第12天,以及第23天壓瘡復原之情形,左圖為正面照,右圖為側面照。 Figure 2 shows the test results of abdominal pressure sore repair in Taiwanese macaques. Figure 2A shows the redness and swelling of the pressure ulcer before treatment. The left photo is the front view, and the right photo is the side photo; Figures 2B to 2D show the pressure ulcer on the 3rd, 12th, and 23rd day after treatment, respectively In the recovery situation, the left picture is a front view, and the right picture is a side view.

3 所示為野生臺灣獼猴尾部外傷修復試驗結果。圖3A所示為處理前尾部感染潰瘍的情況;圖3B至圖3D所示分別為處理後第30天、第50天,以及第75天尾部皮膚復原之情形。 Figure 3 shows the results of the repair test of tail trauma in wild Taiwanese macaques. Figure 3A shows the condition of the tail infection ulcer before treatment; Figures 3B to 3D show the recovery of the tail skin on the 30th day, the 50th day, and the 75th day after the treatment, respectively.

Claims (5)

一種用以產生人工痂皮的傷口修復套組,包含一生物纖維膜,以及一膠原蛋白凝膠,該膠原蛋白凝膠包含約50~250 µg/mL膠原蛋白、約150~250 mg/mL凝膠,以及約0~50 µg/mL抗菌劑。A wound repair kit for producing artificial scabs, including a bio-fiber membrane and a collagen gel. The collagen gel contains about 50-250 µg/mL collagen and about 150-250 mg/mL gel. Glue, and about 0-50 µg/mL antibacterial agent. 一種用以產生人工痂皮的貼片,包含一生物纖維膜,該生物纖維膜具有第一表面及第二表面,該第一表面上具有一膠原蛋白凝膠層,該膠原蛋白凝膠層係用於與一使用者接觸,使該生物纖維膜貼附於該使用者。A patch for producing artificial scabs, comprising a biofiber membrane, the biofiber membrane has a first surface and a second surface, the first surface has a collagen gel layer, the collagen gel layer is It is used to contact with a user and make the bio-fiber membrane stick to the user. 如請求項2所述之貼片,其中該膠原蛋白凝膠包含約50~250 µg/mL膠原蛋白、約150~250 mg/mL凝膠,以及約0~50 µg/mL抗菌劑。The patch according to claim 2, wherein the collagen gel contains about 50-250 µg/mL collagen, about 150-250 mg/mL gel, and about 0-50 µg/mL antibacterial agent. 一種生物纖維膜與膠原蛋白凝膠在製備治療傷口的人工痂皮之用途。A use of biological fiber membrane and collagen gel in preparing artificial crust for treating wounds. 如請求項4所述之用途,其中該膠原蛋白凝膠包含約50~250 µg/mL膠原蛋白、約150~250 mg/mL凝膠,以及約0~50 µg/mL抗菌劑。The use according to claim 4, wherein the collagen gel contains about 50-250 µg/mL collagen, about 150-250 mg/mL gel, and about 0-50 µg/mL antibacterial agent.
TW109115838A 2020-05-13 2020-05-13 Wound healing kit for producing artificial scabs TWI754279B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109115838A TWI754279B (en) 2020-05-13 2020-05-13 Wound healing kit for producing artificial scabs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109115838A TWI754279B (en) 2020-05-13 2020-05-13 Wound healing kit for producing artificial scabs

Publications (2)

Publication Number Publication Date
TW202142276A true TW202142276A (en) 2021-11-16
TWI754279B TWI754279B (en) 2022-02-01

Family

ID=80783280

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109115838A TWI754279B (en) 2020-05-13 2020-05-13 Wound healing kit for producing artificial scabs

Country Status (1)

Country Link
TW (1) TWI754279B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101829320B (en) * 2010-05-20 2012-05-23 佟刚 Collagen gel and preparation method thereof

Also Published As

Publication number Publication date
TWI754279B (en) 2022-02-01

Similar Documents

Publication Publication Date Title
Zhou et al. Rational design of intelligent and multifunctional dressing to promote acute/chronic wound healing
Chopra et al. Strategies and therapies for wound healing: a review
Moraes et al. Bacterial cellulose/collagen hydrogel for wound healing
US20190202998A1 (en) Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor
RU2422133C1 (en) Hydrophylic gel, method of its obtaining (versions), wound covering and based on it bandage means
JPS60122568A (en) Hydrophilic biopolymer copolyelectrolyte
US10836872B2 (en) Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor
Ribeiro et al. Application of stimulus-sensitive polymers in wound healing formulation
US20210393396A1 (en) Dermal layer for grafting having improved graft survival rate and method for producing same
JP3550685B2 (en) Wound healing agent
Zimba et al. Utilizing tilapia fish skin biomaterial for burn wound dressing: A systematic review
Hussain et al. Hyaluronic acid based nanomedicines as promising wound healers for acute-to-chronic wounds: a review of recent updates and emerging trends
CN105727360A (en) Biological material applied to operative skin incision and infectious and non-infectious wound surfaces and application thereof
RU2198685C1 (en) Medicinal polymeric gel material and curative preparations made upon its basis
JP2002104974A (en) Hydrogel therapeutic agent for damaged skin
TWI754279B (en) Wound healing kit for producing artificial scabs
CN103083721B (en) Artificial skin graft for genipin immobilized activin B and preparation method thereof
CN113855849A (en) Dressing composition and preparation method and application thereof
AU2017400651B2 (en) Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use
CN107982568A (en) Degradable biological auxiliary material and its preparation method and application
Mashudi et al. A Novel Dressing for Wound Care Based on Konjac Glucomannan
Ghanim et al. Insight into Topical Preparations for Wound Healing: Traditional and Modern Dressings.
RU2312658C1 (en) Film-forming aerosol for wound protection in treatment and method for its using
TWI845257B (en) Method for manufacturing water solubility oxide wound dressing
Wang et al. Temporary Skin Substitute from Non-Antigenic Dextran Hydrogel